Crescent Grove Advisors’s Xtant Medical Holdings XTNT Stock Holding History

Crescent Grove Advisors’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$146K	Hold	412,024	–	–	0.01%	318
2026 Q2	$173K	Hold	412,024	–	–	0.01%	294
2026 Q1	$230K	Hold	412,024	–	–	0.02%	269
2025 Q4	$323K	Hold	412,024	–	–	0.03%	229
2025 Q3	$267K	Hold	412,024	–	–	0.03%	252
2025 Q2	$304K	Buy	412,024 +200,000	+94%	+$114K	0.03%	215
2025 Q1	$100K	Hold	212,024	–	–	0.01%	257
2024 Q4	$93.9K	Hold	212,024	–	–	0.01%	272
2024 Q3	$143K	Hold	212,024	–	–	0.01%	271
2024 Q2	$134K	Hold	212,024	–	–	0.01%	271
2024 Q1	$248K	Hold	212,024	–	–	0.03%	269
2023 Q4	$240K	Hold	212,024	–	–	0.03%	259
2023 Q3	$233K	Sell	212,024 -50,000	-19%	-$53.7K	0.03%	250
2023 Q2	$244K	Hold	262,024	–	–	0.03%	253
2023 Q1	$167K	Hold	262,024	–	–	0.02%	277
2022 Q4	$173K	Hold	262,024	–	–	0.02%	266
2022 Q3	$189K	Hold	262,024	–	–	0.02%	247
2022 Q2	$136K	Buy	262,024 +100,000	+62%	+$59.2K	0.01%	254
2022 Q1	$110K	Hold	162,024	–	–	0.01%	288
2021 Q4	$91K	Buy	+162,024	New	+$153K	0.01%	288

Other funds holding XTNT

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Wiregrass Investment Management Thomasville, Georgia $144M AUM 19.4% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Crescent Grove Advisors's XTNT Position: Q3 2026 in Review

Crescent Grove Advisors held its Xtant Medical Holdings (XTNT) position steady in Q3 2026 at 412,024 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #318.

Crescent Grove Advisors first reported a position in XTNT in Q4 2021 and has held it in 20 quarters since. The position peaked at $323K in Q4 2025. 24 funds tracked by Wall St. Rank hold XTNT as of Q3 2026.

Crescent Grove Advisors held 412,024 shares of Xtant Medical Holdings worth $146K as of Q3 2026.
Crescent Grove Advisors left its Xtant Medical Holdings share count unchanged in Q3 2026.
Xtant Medical Holdings made up 0.01% of Crescent Grove Advisors's portfolio in Q3 2026, its #318 holding.
Crescent Grove Advisors first reported a position in Xtant Medical Holdings in Q4 2021 and has held it in 20 quarters since.
Crescent Grove Advisors's Xtant Medical Holdings position peaked at $323K in Q4 2025.
24 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2026.

Based on Crescent Grove Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.